Cumulative dose of bevacizumab associates with albuminuria rather than podocyturia in cancer patients

Author(s):
Lankhorst, S.; Baelde, H.J.; Verstijnen, J.A.M.C.; Tije, A.J. ten; Thelen, M.H.M.; Danser, A.H.J.; Meiracker, A.H. van den; Kappers, M.H.W.
Published
2018
Publication type
Article / Letter to editor
Albuminuriaangiogenesis inhibitionnephrinuria
Date issued
2018-11-30
Language
English
Is part of
Journal of the American Society of Hypertension (2018), Vol. 12, no. 11, p. E1-E7
hdl
1887/3195444
doi
10.1016/j.jash.2018.06.005